Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Regan, Meredith M, Dr, Neven, Patrick, MD, Giobbie-Hurder, Anita, MS, Goldhirsch, Aron, MD, Ejlertsen, Bent, MD, Mauriac, Louis, MD, Forbes, John F, FRACS, Smith, Ian, MD, Láng, István, MD, Wardley, Andrew, MD, Rabaglio, Manuela, MD, Price, Karen N, BS, Gelber, Richard D, PhD, Coates, Alan S, MD, Thürlimann, Beat, MD
Published in The lancet oncology (01.11.2011)
Published in The lancet oncology (01.11.2011)
Get full text
Journal Article
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
Aebi, Stefan, Dr, Gelber, Shari, MS, Anderson, Stewart J, PhD, Láng, István, MD, Robidoux, André, MD, Martín, Miguel, MD, Nortier, Johan W R, MD, Paterson, Alexander H G, MD, Rimawi, Mothaffar F, MD, Cañada, José Manuel Baena, MD, Thürlimann, Beat, MD, Murray, Elizabeth, MD, Mamounas, Eleftherios P, MD, Geyer, Charles E, MD, Price, Karen N, BS, Coates, Alan S, MD, Gelber, Richard D, PhD, Rastogi, Priya, MD, Wolmark, Norman, MD, Wapnir, Irene L, MD
Published in The lancet oncology (01.02.2014)
Published in The lancet oncology (01.02.2014)
Get full text
Journal Article
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Finn, Richard S, MD, Crown, John P, Prof, Lang, Istvan, MD, Boer, Katalin, MD, Bondarenko, Igor M, Prof, Kulyk, Sergey O, MD, Ettl, Johannes, MD, Patel, Ravindranath, MD, Pinter, Tamas, MD, Schmidt, Marcus, MD, Shparyk, Yaroslav, MD, Thummala, Anu R, MD, Voytko, Nataliya L, MD, Fowst, Camilla, MD, Huang, Xin, PhD, Kim, Sindy T, BS, Randolph, Sophia, MD, Slamon, Dennis J, Prof
Published in The lancet oncology (01.01.2015)
Published in The lancet oncology (01.01.2015)
Get full text
Journal Article
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
Cunningham, David, Prof, Lang, Istvan, MD, Marcuello, Eugenio, MD, Lorusso, Vito, MD, Ocvirk, Janja, MD, Shin, Dong Bok, MD, Jonker, Derek, MD, Osborne, Stuart, MSc, Andre, Niko, MD, Waterkamp, Daniel, MD, Saunders, Mark P, MD
Published in The lancet oncology (01.10.2013)
Published in The lancet oncology (01.10.2013)
Get full text
Journal Article
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
de Azambuja, Evandro, Dr, Holmes, Andrew P, PhD, Piccart-Gebhart, Martine, MD, Holmes, Eileen, PhD, Di Cosimo, Serena, MD, Swaby, Ramona F, MD, Untch, Michael, MD, Jackisch, Christian, MD, Lang, Istvan, MD, Smith, Ian, MD, Boyle, Frances, MBBS, Xu, Binghe, MD, Barrios, Carlos H, MD, Perez, Edith A, MD, Azim, Hatem A, MD, Kim, Sung-Bae, MD, Kuemmel, Sherko, MD, Huang, Chiun-Sheng, MD, Vuylsteke, Peter, MD, Hsieh, Ruey-Kuen, MD, Gorbunova, Vera, MD, Eniu, Alexandru, MD, Dreosti, Lydia, MD, Tavartkiladze, Natalia, MD, Gelber, Richard D, PhD, Eidtmann, Holger, MD, Baselga, José, MD
Published in The lancet oncology (01.09.2014)
Published in The lancet oncology (01.09.2014)
Get full text
Journal Article